New scan could tell doctors if cancer treatment will work
NCT ID NCT06349512
Summary
This study is testing if a new type of PET scan can predict how well a patient's triple-negative breast cancer will respond to a standard combination of chemotherapy and immunotherapy before they even start treatment. Researchers will scan 60 patients with early-stage, high-risk cancer and compare the new scan to a standard one. The goal is to see if the scan results can accurately forecast which patients will have their cancer completely eliminated by the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GH Diaconesses Croix Saint-Simon
RECRUITINGParis, 75020, France
Contact
Contact
-
HIA Begin
RECRUITINGSaint-Mandé, 94160, France
Contact
Contact
-
Hôpital FOCH
RECRUITINGSuresnes, 92150, France
Contact
Contact
-
Hôpital Privé d'Antony
RECRUITINGAntony, 92160, France
Contact
Contact
-
Institut Curie -site Paris
RECRUITINGParis, 75005, France
Contact
Contact
-
Institut Curie -site St Cloud
RECRUITINGSaint-Cloud, 92210, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.